The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation.

J Virol. 2000 Jun;74(12):5441-51. Unique Identifier : AIDSLINE MED/20283800
Mouland AJ; Mercier J; Luo M; Bernier L; DesGroseillers L; Cohen EA; Departments of Microbiology & Immunology, Universite de; Montreal, Montreal, Quebec H3C 3J7, Canada.


Abstract: Human Staufen (hStau), a double-stranded RNA (dsRNA)-binding protein that is involved in mRNA transport, is incorporated in human immunodeficiency virus type 1 (HIV-1) and in other retroviruses, including HIV-2 and Moloney murine leukemia virus. Sucrose and Optiprep gradient analyses reveal cosedimentation of hStau with purified HIV-1, while subtilisin assays demonstrate that it is internalized. hStau incorporation in HIV-1 is selective, is dependent on an intact functional dsRNA-binding domain, and quantitatively correlates with levels of encapsidated HIV-1 genomic RNA. By coimmunoprecipitation and reverse transcription-PCR analyses, we demonstrate that hStau is associated with HIV-1 genomic RNA in HIV-1-expressing cells and purified virus. Overexpression of hStau enhances virion incorporation levels, and a corresponding, threefold increase in HIV-1 genomic RNA encapsidation levels. This coordinated increase in hStau and genomic RNA packaging had a significant negative effect on viral infectivity. This study is the first to describe hStau within HIV-1 particles and provides evidence that hStau binds HIV-1 genomic RNA, indicating that it may be implicated in retroviral genome selection and packaging into assembling virions.
Keywords: JOURNAL ARTICLE Binding Sites Cell Line Centrifugation, Density Gradient Cloning, Molecular Gene Expression Gene Products, gag/GENETICS/METABOLISM *Genome, Viral Human HIV-1/CHEMISTRY/GENETICS/*METABOLISM/PATHOGENICITY HIV-2/CHEMISTRY/METABOLISM Moloney Leukemia Virus/CHEMISTRY/METABOLISM Mutation/GENETICS Precipitin Tests Protein Precursors/GENETICS/METABOLISM Reverse Transcriptase Polymerase Chain Reaction RNA-Binding Proteins/ANALYSIS/CHEMISTRY/GENETICS/*METABOLISM RNA, Double-Stranded/GENETICS/*METABOLISM RNA, Viral/ANALYSIS/GENETICS/*METABOLISM Substrate Specificity Subtilisin/METABOLISM Support, Non-U.S. Gov't Transfection *Virus Assembly

KWDjournalarticlebindingsitescelllinecentrifugation,densitygradientcloning,moleculargeneexpressiongeneproducts,gag/genetics/metabolismKWDgenome,viralhumanhiv-1/chemistry/genetics/
000930
A0091297


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .